Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Trichiasis

Diseases of the Eye and Adnexa

Trichiasis is a medical term for abnormally positioned eyelashes that grow back toward the eye, touching the cornea or conjunctiva, and it can be caused by infection, inflammation, autoimmune conditions, congenital defects, eyelid agenesis, or trauma such as burns or eyelid injury. Diagnosis is made with a slit lamp, and standard treatment involves removal or destruction of the affected eyelashes by electrolysis, specialized laser, or surgery, though removal with forceps often only provides temporary relief since the eyelashes typically regrow within a few weeks. Severe untreated cases can cause corneal scarring and vision loss.

Facts
Classification
Body System
Lymphatic or Immune System 1
ICD-10 Chapter
VII: Diseases of the Eye and Adnexa 2
Communicable or Non-communicable
Non-Communicable 3
Transmission Route
Non-Transmissible 3
Sources
1. Wikipedia: Trichiasis
WikipediaLead section, body-system statement
Quote, Lead section, body-system statement
This can be caused by infection, inflammation, autoimmune conditions, congenital defects, eyelid agenesis and trauma such as burns or eyelid injury.
View the Source
2. Wikipedia: ICD-10
WikipediaList of chapters, Chapter VII
Quote, List of chapters, Chapter VII
Diseases of the eye and adnexa
View the Source
3. Wikipedia: Non-communicable disease
Wikipedia
  • Lead section, transmission-route statement (inferred from disease-category)
    NCDs include Parkinson's disease, autoimmune diseases, strokes, heart diseases, cancers, diabetes, chronic kidney disease, osteoarthritis, osteoporosis, Alzheimer's disease, cataracts, and others.
  • Named examples section
    NCDs include Parkinson's disease, autoimmune diseases, strokes, heart diseases, cancers, diabetes, chronic kidney disease, osteoarthritis, osteoporosis, Alzheimer's disease, cataracts, and others.
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.